Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David MacLean
The Added Value of Circulating Tumor Cell Enumeration to Standard Markers in Assessing Prognosis in a Metastatic Castration-Resistant Prostate Cancer Population
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Circulating Tumor Cell Analysis in Patients With Progressive Castration-Resistant Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
Isolation and Genomic Analysis of Circulating Tumor Cells From Castration Resistant Metastatic Prostate Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Patient Reported Outcomes in Metastatic Castration-Resistant Prostate Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Quantitative Analysis of Circulating Tumor Cells as a Survival Predictor in Metastatic Castration-Resistant Prostate Cancer: Missing Parts in a Superb Study
Clinical Cancer Research
Cancer Research
Oncology
Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer
Clinical Medicine Insights: Oncology
Oncology
A Genetic Variant in SLC28A3, Rs56350726, Is Associated With Progression to Castration-Resistant Prostate Cancer in a Korean Population With Metastatic Prostate Cancer
Oncotarget
Oncology
Metastatic Castration-Resistant Prostate Cancer: The Emerging Continuum of Care
Journal of the Canadian Urological Association
Oncology
Urology
Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide
Clinical Medicine Insights: Oncology
Oncology
Pcn346 - Disease Specific Cost Analysis of the Nonmetastatic Castration-Resistant Prostate Cancer and Metastatic Castration-Resistant Prostate Cancer Health States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
